Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. März 2020 08:20 ET | Quelle: Exagen, Inc.

Exagen Inc. Partners with Three California Medical Groups to Offer AVISE Testing as Covered In-Network Benefit for Their Patients

SAN DIEGO, CA, March 09, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
18. Februar 2020 08:25 ET | Quelle: Exagen, Inc.

Exagen to Present at Cowen and Company 40th Annual Healthcare Conference

SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
16. Dezember 2019 08:25 ET | Quelle: Exagen, Inc.

Exagen Announces Addition to Russell 3000® and 2000® Indexes

SAN DIEGO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
10. Dezember 2019 08:10 ET | Quelle: Exagen, Inc.

National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board

SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
22. November 2019 08:25 ET | Quelle: Exagen, Inc.

Exagen extends agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management

SAN DIEGO, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
21. November 2019 08:25 ET | Quelle: Exagen, Inc.

Exagen Inc. Announces $26.2 Million Debt Refinancing

SAN DIEGO, Calif., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
20. November 2019 05:15 ET | Quelle: Exagen, Inc.

Exagen Inc. to Participate in the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019

SAN DIEGO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
12. November 2019 16:05 ET | Quelle: Exagen, Inc.

Exagen Inc. Reports Third Quarter 2019 Results

AVISE® Testing Revenue Drives 27% Revenue Growth SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients...
07. November 2019 08:14 ET | Quelle: Exagen, Inc.

Exagen to Participate in Canaccord Genuity 13th Annual MedTech & Diagnostics Forum on November 21, 2019

SAN DIEGO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
29. Oktober 2019 08:00 ET | Quelle: Exagen, Inc.

Exagen to Announce Third Quarter 2019 Financial Results on November 12th, 2019

SAN DIEGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...

Vorherige Seite

Nächste Seite